This article has Open Peer Review reports available.
Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial
© The Author(s). 2017
Received: 29 November 2016
Accepted: 13 July 2017
Published: 19 July 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|29 Nov 2016||Submitted||Original manuscript|
|30 Jan 2017||Reviewed||Reviewer Report - Johannes Nossent|
|3 Mar 2017||Reviewed||Reviewer Report - William Rigby|
|26 Mar 2017||Author responded||Author comments - Harindu Wijesinghe|
|Resubmission - Version 2|
|26 Mar 2017||Submitted||Manuscript version 2|
|30 Mar 2017||Reviewed||Reviewer Report - Johannes Nossent|
|24 Apr 2017||Reviewed||Reviewer Report - William Rigby|
|21 May 2017||Author responded||Author comments - Harindu Wijesinghe|
|Resubmission - Version 3|
|21 May 2017||Submitted||Manuscript version 3|
|25 May 2017||Reviewed||Reviewer Report - Johannes Nossent|
|17 Jun 2017||Author responded||Author comments - Harindu Wijesinghe|
|Resubmission - Version 4|
|17 Jun 2017||Submitted||Manuscript version 4|
|13 Jul 2017||Editorially accepted|
|19 Jul 2017||Article published||10.1186/s12891-017-1673-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.